336 related articles for article (PubMed ID: 9438134)
1. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
[TBL] [Abstract][Full Text] [Related]
2. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect.
Logeart D; Prigent-Richard S; Boisson-Vidal C; Chaubet F; Durand P; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):385-90. PubMed ID: 9438135
[TBL] [Abstract][Full Text] [Related]
3. Heparin binding, internalization, and metabolism in vascular smooth muscle cells: I. Upregulation of heparin binding correlates with antiproliferative activity.
Letourneur D; Caleb BL; Castellot JJ
J Cell Physiol; 1995 Dec; 165(3):676-86. PubMed ID: 7593248
[TBL] [Abstract][Full Text] [Related]
4. Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: comparison between heparin-sensitive and heparin-resistant cultures.
Bârzu T; Pascal M; Maman M; Roque C; Lafont F; Rousselet A
J Cell Physiol; 1996 Apr; 167(1):8-21. PubMed ID: 8698843
[TBL] [Abstract][Full Text] [Related]
5. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
6. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
[TBL] [Abstract][Full Text] [Related]
7. Heparin binding, internalization, and metabolism in vascular smooth muscle cells: II. Degradation and secretion in sensitive and resistant cells.
Letourneur D; Caleb BL; Castellot JJ
J Cell Physiol; 1995 Dec; 165(3):687-95. PubMed ID: 7593249
[TBL] [Abstract][Full Text] [Related]
8. Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin.
Caleb BL; Hardenbrook M; Cherington V; Castellot JJ
J Cell Physiol; 1996 May; 167(2):185-95. PubMed ID: 8613458
[TBL] [Abstract][Full Text] [Related]
9. Characterization of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment.
Bârzu T; Herbert JM; Desmoulière A; Carayon P; Pascal M
J Cell Physiol; 1994 Aug; 160(2):239-48. PubMed ID: 8040184
[TBL] [Abstract][Full Text] [Related]
10. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin.
Reilly CF
J Cell Physiol; 1990 Feb; 142(2):342-51. PubMed ID: 2154504
[TBL] [Abstract][Full Text] [Related]
11. Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.
Religa P; Kazi M; Thyberg J; Gaciong Z; Swedenborg J; Hedin U
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):419-26. PubMed ID: 11112459
[TBL] [Abstract][Full Text] [Related]
12. A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation.
Benezra M; Vogel T; Ben-Sasson SA; Panet A; Sehayek E; Al-Haideiri M; Decklbaum RJ; Vlodavsky I
J Cell Biochem; 2001; 81(1):114-27. PubMed ID: 11180402
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
[TBL] [Abstract][Full Text] [Related]
14. Different action of heparin and fucoidan on arterial smooth muscle cell proliferation and thrombospondin and fibronectin metabolism.
Vischer P; Buddecke E
Eur J Cell Biol; 1991 Dec; 56(2):407-14. PubMed ID: 1802722
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor.
Reilly CF; Fritze LM; Rosenberg RD
J Cell Physiol; 1987 May; 131(2):149-57. PubMed ID: 3495540
[TBL] [Abstract][Full Text] [Related]
16. Protection of transforming growth factor-beta 1 activity by heparin and fucoidan.
McCaffrey TA; Falcone DJ; Vicente D; Du B; Consigli S; Borth W
J Cell Physiol; 1994 Apr; 159(1):51-9. PubMed ID: 7511146
[TBL] [Abstract][Full Text] [Related]
17. Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications.
Fonseca RJ; Santos GR; Mourão PA
Thromb Haemost; 2009 Nov; 102(5):829-36. PubMed ID: 19888516
[TBL] [Abstract][Full Text] [Related]
18. Fucan inhibits Chinese hamster ovary cell (CHO) adhesion to fibronectin by binding to the extracellular matrix.
Rocha HA; Franco CR; Trindade ES; Veiga SS; Leite EL; Nader HB; Dietrich CP
Planta Med; 2005 Jul; 71(7):628-33. PubMed ID: 16041648
[TBL] [Abstract][Full Text] [Related]
19. Effects of heparin and related sulfated polysaccharides on tissue factor expression induced by mitogenic and non-mitogenic factors in human vascular smooth muscle cells.
Xuereb JM; Herbert JM; Sie P; Boneu B; Constans J
Thromb Haemost; 1999 Jan; 81(1):151-6. PubMed ID: 10348708
[TBL] [Abstract][Full Text] [Related]
20. Binding and internalization of heparin by vascular smooth muscle cells.
Castellot JJ; Wong K; Herman B; Hoover RL; Albertini DF; Wright TC; Caleb BL; Karnovsky MJ
J Cell Physiol; 1985 Jul; 124(1):13-20. PubMed ID: 3930515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
